Anemia, Sickle Cell
13 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Anemia, Hematologic Diseases, Hemoglobinopathies
Narrower: Vaso-Occlusive Crises 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Benserazide Only Product for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BMS-986470 for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BMS-986470 + Famotidine + PANTOPRAZOLE for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BMS-986470 + Placebo for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) for anemia, sickle cell | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Crizanlizumab for anemia, sickle cell | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for anemia, sickle cell | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| EDIT-301 for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Exagamglogene autotemcel for anemia, sickle cell | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| GVHD prophylaxis regimen + RIC regimen for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxycarbamide for anemia, sickle cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Iloprost for vaso-occlusive crises | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation for anemia, sickle cell | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.